Drug Profile
HBV 002
Alternative Names: HBV-002; West Nile virus vaccine - Hawaii Biotech; WN 80ELatest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Hawaii Biotech
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported West Nile virus infections
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for phase-I development in West Nile virus infections(Prevention, In volunteers) in USA (Parenteral, Injection)
- 27 Feb 2020 Phase I development is ongoing in West Nile virus infections in USA
- 28 May 2018 No recent reports of development identified for phase-I development in West Nile virus infections(Prevention, In volunteers) in USA (Parenteral, Injection)